Dextromethorphan and guaifenesin use ought to be monitored cautiously in people with "very poor metabolizer" CYP2D6 enzyme stages and sufferers who will be sedated. This mixture medication has a large median harmful dose (TD50) to median effective dose (ED50) ratio (or therapeutic index) in these patients. Speaking to your teenager https://kylerrkzrf.blogocial.com/dextromethorphan-dxm-for-sale-in-germany-can-be-fun-for-anyone-66124656